PolarityTE has announced it has received notification of being awarded a Phase I Small Business Innovation Research grant from the National Institutes of Health (NIH) for an application titled “Fluid Management System for Point of Care Device for Novel Regenerative Treatment for Chronic Wounds”. The Phase I grant, which totals approximately US$245,000, is funded over a six-month period and will support research to apply for a subsequent larger Phase II grant.
“I am proud of the hard work the PolarityTE team dedicated to pursuing this grant and we are pleased to see that work validated by an award from the NIH,” comments David Seaburg, chief executive officer of PolarityTE. He continues: “We will continue to leverage our scientific team’s talent and pursue opportunities we believe will add value to the SkinTE franchise.”
“We are incredibly excited to receive this grant and look forward to working with the NIH to generate research supporting the development of a point-of-care device,” says Nik Sopko, chief sientific officer. “We believe the ability to use products like SkinTE in a point-of-care setting will help many more patients gain access to novel treatments that can address unmet needs and deliver meaningful improvements to the standard of care.”
